Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive Pharma News

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

  • 19 October 2025
  • 2 weeks ago

Intas Pharma appoints Gagan Bharadwaj as Executive Vice President - Supply Chain Management Pharma News

Intas Pharma appoints Gagan Bharadwaj as Executive Vice President - Supply Chain Management

  • 15 October 2025
  • 2 weeks ago

Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab Pharma News

Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab

  • 14 October 2025
  • 2 weeks ago

30 Pharma Firms Under MPFDA, CDSCO Scanner in Madhya Pradesh State News

30 Pharma Firms Under MPFDA, CDSCO Scanner in Madhya Pradesh

  • 13 October 2025
  • 2 weeks ago

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol Pharma News

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol

  • 30 September 2025
  • 1 month ago

Intas Pharma appoints Akash Kalal as General Manager - API Production Pharma News

Intas Pharma appoints Akash Kalal as General Manager - API Production

  • 29 September 2025
  • 1 month ago

Intas Pharma appoints Ajay Tiwari as President - HR Pharma News

Intas Pharma appoints Ajay Tiwari as President - HR

  • 23 September 2025
  • 1 month ago

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema Pharma News

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema

  • 17 September 2025
  • 1 month ago

Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD Pharma News

Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD

  • 11 September 2025
  • 1 month ago

Indian Pharma Sees Robust Growth Of 51.5 Percent In April Sales: AIOCD-AWACS Report Delhi

Indian Pharma Sees Robust Growth Of 51.5 Percent In April Sales: AIOCD-AWACS Report

  • 16 July 2025
  • 3 months ago

Recent News

SR Post VACANCIES At ESIC Model Hospital Noida, Ch...

  • 02 November, 2025

Pathologist's signature on medical reports not mus...

  • 02 November, 2025

UP Eyes Japanese Investment: 125 Pharma Giants Inv...

  • 02 November, 2025

Delhi Govt to recruit 1,593 senior resident doctor...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.